0001209191-20-031792.txt : 20200522
0001209191-20-031792.hdr.sgml : 20200522
20200522170012
ACCESSION NUMBER: 0001209191-20-031792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200522
DATE AS OF CHANGE: 20200522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HALE DAVID F
CENTRAL INDEX KEY: 0001024004
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 20906751
MAIL ADDRESS:
STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-21
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001024004
HALE DAVID F
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2020-05-21
4
P
0
17412
A
716818
I
By Hale BioPharma Ventures LLC
Common Stock
18346
I
By Hale Trading Company
Warrants
2.51
2020-05-21
4
P
0
8706
A
2025-11-21
Common Stock
8706
8706
I
By Hale BioPharma Ventures LLC
Pursuant to the Securities Purchase Agreement, dated as of May 19, 2020, by and among the Issuer and the several purchasers party thereto, on May 21, 2020 the Reporting Person purchased the securities reported herein for aggregate consideration $44,792.37.
The warrants are currently exercisable.
/s/ Hazel M. Aker, Attorney-in-fact
2020-05-22